End-of-day quote
Shenzhen S.E.
23:00:00 15/05/2024 BST
|
5-day change
|
1st Jan Change
|
2.06
CNY
|
0.00%
|
|
-4.63%
|
-37.00%
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Capitalization
1 |
11,810
|
2,570
|
2,881
|
2,453
|
3,696
|
3,108
|
Enterprise Value (EV)
1 |
12,028
|
2,894
|
3,183
|
2,657
|
4,078
|
3,490
|
P/E ratio
|
156
x
|
76.5
x
|
385
x
|
-8.26
x
|
-48.6
x
|
-11.9
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
60.6
x
|
6.09
x
|
18.5
x
|
21.5
x
|
22
x
|
6.21
x
|
EV / Revenue
|
61.7
x
|
6.85
x
|
20.5
x
|
23.2
x
|
24.3
x
|
6.97
x
|
EV / EBITDA
|
424
x
|
-6,566
x
|
232
x
|
-40.3
x
|
463
x
|
-68.5
x
|
EV / FCF
|
-455
x
|
-13
x
|
93.2
x
|
13.5
x
|
48
x
|
11.8
x
|
FCF Yield
|
-0.22%
|
-7.69%
|
1.07%
|
7.43%
|
2.08%
|
8.45%
|
Price to Book
|
9.54
x
|
2.01
x
|
2.24
x
|
2.82
x
|
4.3
x
|
5.43
x
|
Nbr of stocks (in thousands)
|
840,000
|
840,000
|
840,000
|
840,000
|
840,000
|
840,000
|
Reference price
2 |
14.06
|
3.060
|
3.430
|
2.920
|
4.400
|
3.700
|
Announcement Date
|
26/04/18
|
28/04/19
|
29/04/20
|
29/04/21
|
28/04/22
|
28/04/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net sales
1 |
194.9
|
422.4
|
155.3
|
114.3
|
168.1
|
500.7
|
EBITDA
1 |
28.37
|
-0.4407
|
13.69
|
-65.88
|
8.811
|
-50.93
|
EBIT
1 |
11.98
|
-14.53
|
0.7202
|
-75.18
|
-4.44
|
-69.64
|
Operating Margin
|
6.14%
|
-3.44%
|
0.46%
|
-65.75%
|
-2.64%
|
-13.91%
|
Earnings before Tax (EBT)
1 |
82.12
|
60.59
|
12.68
|
-301.6
|
-69.86
|
-289.9
|
Net income
1 |
71.92
|
36.84
|
7.441
|
-297.1
|
-75.98
|
-256.8
|
Net margin
|
36.89%
|
8.72%
|
4.79%
|
-259.85%
|
-45.2%
|
-51.29%
|
EPS
2 |
0.0900
|
0.0400
|
0.008900
|
-0.3537
|
-0.0905
|
-0.3100
|
Free Cash Flow
1 |
-26.43
|
-222.4
|
34.16
|
197.4
|
84.95
|
294.9
|
FCF margin
|
-13.56%
|
-52.65%
|
22%
|
172.63%
|
50.54%
|
58.91%
|
FCF Conversion (EBITDA)
|
-
|
-
|
249.52%
|
-
|
964.17%
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
459.12%
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
26/04/18
|
28/04/19
|
29/04/20
|
29/04/21
|
28/04/22
|
28/04/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net Debt
1 |
218
|
324
|
301
|
204
|
382
|
382
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
7.687
x
|
-734.1
x
|
22.01
x
|
-3.095
x
|
43.3
x
|
-7.508
x
|
Free Cash Flow
1 |
-26.4
|
-222
|
34.2
|
197
|
85
|
295
|
ROE (net income / shareholders' equity)
|
6.09%
|
2.76%
|
0.57%
|
-27.6%
|
-8.44%
|
-38.7%
|
ROA (Net income/ Total Assets)
|
0.5%
|
-0.51%
|
0.02%
|
-3.02%
|
-0.18%
|
-2.54%
|
Assets
1 |
14,380
|
-7,296
|
30,125
|
9,823
|
42,903
|
10,111
|
Book Value Per Share
2 |
1.470
|
1.520
|
1.530
|
1.040
|
1.020
|
0.6800
|
Cash Flow per Share
2 |
0.1900
|
0.1200
|
0.0900
|
0.2300
|
0.2300
|
0.1400
|
Capex
1 |
8.07
|
12.2
|
0.18
|
0.59
|
5.74
|
24
|
Capex / Sales
|
4.14%
|
2.89%
|
0.12%
|
0.52%
|
3.41%
|
4.79%
|
Announcement Date
|
26/04/18
|
28/04/19
|
29/04/20
|
29/04/21
|
28/04/22
|
28/04/23
|
|
1st Jan change
|
Capi.
|
---|
| -37.00% | 240M | | +19.22% | 84.52B | | -27.14% | 72.21B | | +4.65% | 27.74B | | -6.23% | 17.97B | | +1.60% | 17.46B | | +3.30% | 15.82B | | +7.44% | 13.55B | | +9.91% | 13.31B | | +73.32% | 13.32B |
Other Healthcare Facilities & Services
|